Cargando…
Population Pharmacokinetics of Lithium in Young Pediatric Patients With Intellectual Disability
Background: Lithium is a well-established treatment for bipolar disorders and has been shown to be neuroprotective, and thus low doses might be useful for the treatment of childhood brain injury and neurological sequelae. However, pharmacokinetic (PK) data in children are limited. This study was to...
Autores principales: | Yuan, Junying, Zhang, Bohao, Xu, Yiran, Zhang, Xiaoli, Song, Juan, Zhou, Wenhao, Hu, Kai, Zhu, Dengna, Zhang, Lirong, Shao, Fengmin, Zhang, Shusheng, Ding, Junjie, Zhu, Changlian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082156/ https://www.ncbi.nlm.nih.gov/pubmed/33935755 http://dx.doi.org/10.3389/fphar.2021.650298 |
Ejemplares similares
-
Lithium Treatment Is Safe in Children With Intellectual Disability
por: Yuan, Junying, et al.
Publicado: (2018) -
Autophagy-Related Gene 7 Polymorphisms and Cerebral Palsy in Chinese Infants
por: Xia, Lei, et al.
Publicado: (2019) -
Inhibition of Colony Stimulating Factor 1 Receptor Suppresses Neuroinflammation and Neonatal Hypoxic-Ischemic Brain Injury
por: Zhang, Bohao, et al.
Publicado: (2021) -
Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder
por: Jin, Zi-bin, et al.
Publicado: (2022) -
Neonatal Feeding Trajectories in Mothers With Bipolar Disorder Taking Lithium: Pharmacokinetic Data
por: Imaz, Maria Luisa, et al.
Publicado: (2021)